Cosimo Commisso: How Does RAS Inhibition Trigger Metabolic Adaptation in Pancreatic Cancer?
Cosimo Commisso/LinkedIn

Cosimo Commisso: How Does RAS Inhibition Trigger Metabolic Adaptation in Pancreatic Cancer?

Cosimo Commisso, Professor and Deputy Director, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, shared on LinkedIn:

“Join us Dec. 9-12 for the 57th Annual Meeting of the American Pancreatic Association, being held in Los Angeles.

I will be presenting the work of talented lab members Guillem Lambies and Aaliyah Balagtas on how macropinocytosis is a targetable metabolic adaptation that occurs during RAS inhibition in pancreatic cancer.

Link:”

You may also be interested in: World Pancreatic Cancer Day 2026: From Silent Symptoms to the Urgent Need for Earlier Diagnosis

Cosimo Commisso: How Does RAS Inhibition Trigger Metabolic Adaptation in Pancreatic Cancer?